BCO vs BSX · P/E 25, rev $5.01B vs P/E 20, rev $16.75B
Brinks Company (BCO) versus Boston Scientific Corp (BSX) — a side-by-side from cached financials, not a winner call.
Brinks Company (BCO) is a security & protection services company listed on US.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Latest reported BCO revenue for 2024-12-31 was $5.01B. Net income was $174.7M. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. BCO currently screens at market cap $3.97B and trailing P/E 25.4.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
BCO currently screens at market cap $3.97B and trailing P/E 25.4. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Not investment advice. Open the BCO and BSX stock pages for the full models.
Not investment advice.